Valuation : Getinge AB

Market Cap 65.86B 6.88B 5.92B 5.57B 5.09B 9.52B 650B 9.55B 25.56B 333B 25.85B 25.29B 1,074B P/E 2026 *
20.9x
P/E 2027 * 18.8x
Enterprise Value 74.07B 7.74B 6.66B 6.27B 5.73B 10.71B 731B 10.74B 28.74B 375B 29.07B 28.44B 1,208B EV / Sales 2026 *
2.1x
EV / Sales 2027 * 1.93x
Free-Float
79.13%
Yield 2026 *
2.14%
Yield 2027 * 2.32%
1 week-2.39%
Current month-1.14%
1 month-0.73%
3 months+21.24%
6 months+16.43%
Current year+7.16%
1 week 21.53
Extreme 21.53
22.19
1 month 21.52
Extreme 21.52
22.28
3 years 14.2
Extreme 14.2
22.28
5 years 14.2
Extreme 14.2
43.02
10 years 0
Extreme 0
43.02
Manager TitleAgeSince
Chief Executive Officer 54 2017-04-30
Director of Finance/CFO 48 2024-03-30
Compliance Officer 47 2020-09-30
Director TitleAgeSince
Chairman 65 2019-04-22
Chairman 75 -
Director/Board Member 70 2006-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.09%-0.77%+14.73%+33.72% 6.88B
+0.32%+0.15%+14.46%+22.92% 12.69B
-0.98%-2.26%+15.25%+26.04% 6.88B
-2.33%+15.85% - - 6.54B
-2.41%-7.59%+29.38%+19.88% 5.99B
+3.02%+1.31%-18.75%+53.45% 5.21B
+0.51%-1.90%-30.30%-22.46% 3.83B
+1.70%+0.67%+46.09%-16.25% 2.09B
-2.02%-3.00%-1.85%+125.58% 1.72B
+2.63%-1.57%+48.17%-13.79% 1.64B
Average +0.05%+0.45%+13.02%+25.46% 5.18B
Weighted average by Cap. -0.22%+1.05%+11.17%+25.01%

Financials

2026 *2027 *
Net sales 35.27B 3.69B 3.17B 2.98B 2.73B 5.1B 348B 5.11B 13.68B 179B 13.84B 13.54B 575B 37.22B 3.89B 3.35B 3.15B 2.88B 5.38B 367B 5.4B 14.44B 188B 14.61B 14.29B 607B
Net income 3.16B 330M 284M 267M 244M 456M 31.14B 458M 1.22B 15.98B 1.24B 1.21B 51.47B 3.5B 366M 315M 296M 270M 506M 34.53B 507M 1.36B 17.71B 1.37B 1.34B 57.07B
Net Debt 8.21B 858M 739M 695M 635M 1.19B 81.04B 1.19B 3.19B 41.58B 3.22B 3.15B 134B 6B 627M 539M 507M 464M 867M 59.18B 870M 2.33B 30.36B 2.35B 2.3B 97.82B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
-
Date Price Change
26-09-04 €21.69 -1.09%
26-09-03 €21.93 +0.27%
26-09-02 €21.87 -0.32%
26-09-01 €21.94 0.00%
26-08-31 €21.94 -1.26%
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
241.80SEK
Average target price
241.60SEK
Spread / Average Target
-0.08%

Quarterly revenue - Rate of surprise